HMGB1P5: A Potential Drug Target for Cancer (G10354)

Target Name: HMGB1P5

NCBI ID: G10354

HMGB1P5

HMGB1P5: A Potential Drug Target for Cancer

HMGB1P5 (HMGB1L15) is a protein that is expressed in various tissues throughout the body. It is a key regulator of cell growth and differentiation, and has been identified as a potential drug target in the field of cancer.

HMGB1P5 is a heat- shock protein (HSP) that is expressed in high levels in response to thermal stress. It is a transmembrane protein that is involved in a variety of cellular processes, including cell signaling, DNA replication, and stress response.

One of the key functions of HMGB1P5 is its role in cell signaling. It is a negative regulator of the NF-kappa pathway, which is a well-known signaling pathway that is involved in cell growth, differentiation, and repair. NF-kappa is a cytoplasmic protein that is involved in the regulation of cell growth and differentiation by promoting the production of new cells and by inhibiting the growth of cells that are no longer needed.

HMGB1P5 is known to play a negative role in the NF-kappa pathway by regulating the activity of the transcription factor SMAD. SMAD is a key regulator of the NF-kappa pathway, and is involved in the regulation of cell growth and differentiation by promoting the production of new cells and by inhibiting the growth of cells that are no longer needed.

HMGB1P5 is also involved in the regulation of DNA replication. It is a critical regulator of the DNA replication process, and is involved in the regulation of cell division and the maintenance of genetic information.

In addition to its role in cell signaling, HMGB1P5 is also known to play a role in the regulation of stress response. It is a heat- shock protein, and is expressed in high levels in response to thermal stress. It is involved in the regulation of cellular stress response, and is thought to play a key role in the regulation of cell death in response to stress.

HMGB1P5 is also a potential biomarker for cancer. It is often expressed in various tissues, including the breast, lung, and gastrointestinal tract, and is thought to be involved in the regulation of cancer growth and progression. It is also a potential target for new cancer therapies, and is being targeted by researchers in the field of cancer to develop new treatments.

In conclusion, HMGB1P5 is a protein that is expressed in various tissues throughout the body. It is a key regulator of cell growth and differentiation, and has been identified as a potential drug target in the field of cancer. Further research is needed to fully understand the role of HMGB1P5 in cell signaling and its potential as a biomarker for cancer.

Protein Name: High Mobility Group Box 1 Pseudogene 5

The "HMGB1P5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HMGB1P5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets